Last updated: 2026-09-27 02:24:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Microbot Medical, Inc. (MBOT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1,28, with a market capitalization of $87,99M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,26 to $3,46. This page covers its latest market performance, valuation, price trends and company information.
$87,99M | |
$1,32 | |
$192,03 | |
$0,82 | |
$1,31 | |
439,06K | |
646,44K | |
-- | |
$3,46 | |
$1,26 | |
-- | |
-- |
Microbot Medical, Inc. (MBOT) last closed at $1,31 as of 2026-09-25 23:31:00, unchanged from the previous close of $1,31.
During the latest regular trading session, MBOT traded between $0,82 and $192,03, with a volume of 439,06K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Microbot Medical, Inc. (MBOT) moved from $1,42 to $1,28, representing a decline of 10,21% ($0,15).
The stock traded between $1,26 and $1,47 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 606,35 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0,7%
MBOT is currently trading at $1,28, placing it 0,7% of the way from its 52-week low of $1,26 to its 52-week high of $3,46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Microbot Medical, Inc. (MBOT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.